Furthermore, the association between BAFF levels and thyroid-associated ophthalmopathy, along with variations depending on the type of immunosuppressive therapy, supports its relevance as both a biomarker and a potential therapeutic target in autoimmune thyroid pathology. Here, TNFSF13B is linked to autoimmune thyroid disease.